Dive into clinical trial budgets with Gary Quashie. Discover hidden costs, biggest risks, and smartest strategies for success

Explore the future of clinical research as Summit Chair Jasmina Jankicevic delves into the evolving landscape of CROs.

It’s widely reported that as of 2023 over 49% of clinical trial expenditure was allocated to outsourced services, demonstrating a trend...

Managing Clinical Trials: Navigating Challenges and Ensuring Success, interview with Helen Johansen Blanco, COO of Node Pharma In the...

Discover the pivotal role of medical writing in clinical trials. Learn from Dr. Lisa Chamberlain James, Senior Partner at Trilogy.

Phill Gallacher, SVP at Cullinan Therapeutics, shares insights on navigating the biopharma startup journey from pre-IPO to clinical success

In Conversation with Barry Henderson, Northern Ireland Emerging as Clinical Trial Hub Northern Ireland is rapidly developing into a...

In Conversation with Gary Quashie: The Evolving Clinical Trial Landscape in the UK   The UK’s clinical trial landscape has undergone...

Navigating the Complex World of Clinical Trial Contracts Following October's COG Europe meeting Pharmaceutical Business Conference...

Introducing Kalyan Obalampalli: A Leader in Clinical Trial Vendor Selection and Management Kalyan Obalampalli brings over 20 years of...

Ensuring CRO Accountability in Clinical Research I recently had the opportunity to interview Paula Arranz Gutiérrez, an experienced...

Randomization in clinical trials ensures unbiased assignment of participants to treatment groups. It minimizes confounding variables and...

Collaboration with non-profit organizations plays a major role in clinical research, and to learn more, I sat down with Joan Chambers to...

Industry conferences in the clinical research space widely benefit attendees, accelerate industry-wide innovation, as well as enabling...

In continuation of our series of interviews, Sam Vakili, Founder & CEO, INVEST.IN.TEK shared with me his views on the impact of European...

In continuation of our series of interviews, Sam Vakili, Founder & CEO, INVEST.IN.TEK shared with me his opinion on the current trends...

Since the pandemic there is an increasing number of clinical trials being initiated, outpacing the capacity of available study sites. In...

In January 2022 the European Medicines Agency (EMA) introduced the new Clinical Trials Information System (CTIS). Alongside new Clinical...

Maintaining sufficient financial oversight in clinical studies will present several challenges, I sat down with Helen Blanco, Vice...